439 related articles for article (PubMed ID: 10966249)
1. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
van Iperen CE; Gaillard CA; Kraaijenhagen RJ; Braam BG; Marx JJ; van de Wiel A
Crit Care Med; 2000 Aug; 28(8):2773-8. PubMed ID: 10966249
[TBL] [Abstract][Full Text] [Related]
2. Blood conservation in the critically ill.
Thomas J; Martinez A
Am J Health Syst Pharm; 2007 Aug; 64(16 Suppl 11):S11-8. PubMed ID: 17687066
[TBL] [Abstract][Full Text] [Related]
3. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
5. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness.
Rodriguez RM; Corwin HL; Gettinger A; Corwin MJ; Gubler D; Pearl RG
J Crit Care; 2001 Mar; 16(1):36-41. PubMed ID: 11230723
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study.
DeAngelo AJ; Bell DG; Quinn MW; Long DE; Ouellette DR
Crit Care; 2005 Jun; 9(3):R172-6. PubMed ID: 15987387
[TBL] [Abstract][Full Text] [Related]
8. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
Voils SA; Harpe SH; Brophy GM
Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of epoetin alfa in critically ill patients.
Corwin HL; Gettinger A; Fabian TC; May A; Pearl RG; Heard S; An R; Bowers PJ; Burton P; Klausner MA; Corwin MJ;
N Engl J Med; 2007 Sep; 357(10):965-76. PubMed ID: 17804841
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss.
Arroliga AC; Guntupalli KK; Beaver JS; Langholff W; Marino K; Kelly K
Crit Care Med; 2009 Apr; 37(4):1299-307. PubMed ID: 19242343
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin, iron metabolism, and red blood cell production.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9. PubMed ID: 8723573
[TBL] [Abstract][Full Text] [Related]
13. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Multicenter Study Group.
Bessho M; Hirashima K; Asano S; Ikeda Y; Ogawa N; Tomonaga M; Toyama K; Nakahata T; Nomura T; Mizoguchi H; Yoshida Y; Niitsu Y; Kohgo Y
Eur J Haematol; 1997 Apr; 58(4):265-72. PubMed ID: 9186538
[TBL] [Abstract][Full Text] [Related]
14. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
[TBL] [Abstract][Full Text] [Related]
15. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
Blood; 1996 Jun; 87(11):4824-30. PubMed ID: 8639855
[TBL] [Abstract][Full Text] [Related]
16. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients.
Sowade O; Sowade B; Brilla K; Franke W; Stephan P; Gross J; Scigalla P; Warnke H
Am J Hematol; 1997 Jun; 55(2):89-96. PubMed ID: 9209004
[TBL] [Abstract][Full Text] [Related]
18. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients.
von Ahsen N; Müller C; Serke S; Frei U; Eckardt KU
Crit Care Med; 1999 Dec; 27(12):2630-9. PubMed ID: 10628602
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
20. Use of epoetin alfa in critically ill patients.
Pajoumand M; Erstad BL; Camamo JM
Ann Pharmacother; 2004 Apr; 38(4):641-8. PubMed ID: 14966258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
